doi: 10.1038/s41392-024-01931-z, Summary Keywords central nervous system, feeding behavior, GLP-1 receptor agonists, gutbrain axis, obesity Citation OConnor RM (2026) Revisiting food addiction in the era of GLP-1based obesity pharmacotherapy via neural reward pathways linking feeding and substance use
The FDA has approved semaglutide for chronic weight management under the brand name Wegovy
One of them required intravenous (IV) administration of fluids
Since the liver is responsible for many important functions in the body, these compounds can provide added nutritional support, especially for clients looking to support liver function as part of their overall wellness routine
During the week, I can get really lazy about making myself lunch, says Scully
Note: If you are traveling with semaglutide, remember to keep it at the recommended temperature